[The evaluation of the antianginal effect of Corvaton-Retard in patients with ischemic heart disease by using paired bicycle ergometry].
Runovich
A A
AA
Verkhozin
I A
IA
Kuril'skaia
T E
TE
Zuev
A V
AV
D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D005080:Exercise Test / Q000187:drug effects* / Q000379:methods / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008875:Middle Aged; D008981:Molsidomine / Q000627:therapeutic use*; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000503:physiopathology; D014665:Vasodilator Agents / Q000627:therapeutic use*
D003692:Delayed-Action Preparations; D014665:Vasodilator Agents; D008981:Molsidomine